company background image
KAEF

Kimia Farma IDX:KAEF Stock Report

Last Price

Rp825.00

Market Cap

Rp4.6t

7D

-0.6%

1Y

-37.3%

Updated

23 Sep, 2023

Data

Company Financials

KAEF Stock Overview

PT Kimia Farma Tbk engages in the manufacturing and sale of pharmaceutical products and herbal medicines in Indonesia.

KAEF fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance1/6
Financial Health3/6
Dividends0/6

PT Kimia Farma Tbk Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Kimia Farma
Historical stock prices
Current Share PriceRp825.00
52 Week HighRp1,770.00
52 Week LowRp695.00
Beta-0.049
1 Month Change-0.60%
3 Month Change5.10%
1 Year Change-37.26%
3 Year Change-71.35%
5 Year Change-67.65%
Change since IPO292.86%

Recent News & Updates

Recent updates

Shareholder Returns

KAEFID PharmaceuticalsID Market
7D-0.6%0.5%0.5%
1Y-37.3%-5.2%0.5%

Return vs Industry: KAEF underperformed the ID Pharmaceuticals industry which returned -5.2% over the past year.

Return vs Market: KAEF underperformed the ID Market which returned 0.5% over the past year.

Price Volatility

Is KAEF's price volatile compared to industry and market?
KAEF volatility
KAEF Average Weekly Movement3.8%
Pharmaceuticals Industry Average Movement3.0%
Market Average Movement5.2%
10% most volatile stocks in ID Market12.1%
10% least volatile stocks in ID Market2.4%

Stable Share Price: KAEF is not significantly more volatile than the rest of ID stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: KAEF's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
181711,668David Utamahttps://kimiafarma.co.id

PT Kimia Farma Tbk engages in the manufacturing and sale of pharmaceutical products and herbal medicines in Indonesia. The company operates through Manufacturing, Distribution, Retail, and Other Services segments. It provides generic, ethical, license and narcotic medicines, over the counter medicines, raw materials, medicines, medical devices, and cosmetic products, as well as rapid test diagnostic tools.

PT Kimia Farma Tbk Fundamentals Summary

How do Kimia Farma's earnings and revenue compare to its market cap?
KAEF fundamental statistics
Market CapRp4.59t
Earnings (TTM)Rp10.19b
Revenue (TTM)Rp10.13t

450.3x

P/E Ratio

0.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
KAEF income statement (TTM)
RevenueRp10.13t
Cost of RevenueRp6.63t
Gross ProfitRp3.50t
Other ExpensesRp3.49t
EarningsRp10.19b

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)1.83
Gross Margin34.51%
Net Profit Margin0.10%
Debt/Equity Ratio84.9%

How did KAEF perform over the long term?

See historical performance and comparison